Coronary Heart Disease Treatment
Coronary Heart Disease Treatment
Coronary treatment is three options and one comparison. Medicine is the foundation for every patient — it is what stabilises the plaques and what prevents the next event, and for many patients it is also the whole treatment. Stents reopen the arteries that are genuinely starving the muscle, and they are the treatment of the acute syndromes. Bypass rebuilds the supply when the anatomy is more than a wire should be asked to fix. Which of the three — or which combination — is decided by the anatomy, the state of the muscle and the patient in front of you, not by habit; and the page that follows is organised around that comparison.
The medical foundation: what every patient takes, and why
Whatever else is done — stent, bypass, or neither — every patient with coronary disease is on a medical foundation, and it is worth understanding why, because it is doing two jobs at once: relieving symptoms and preventing the next event. The drugs work on different parts of the problem:
| Drug class | What it does | Why it is there |
|---|---|---|
| Antiplatelet therapy | Aspirin, usually with a second agent (a P2Y12 inhibitor) for a defined period after a stent or an acute event | Makes platelets less likely to form the clot that converts a plaque into an emergency |
| Statin | Lowers LDL cholesterol and stabilises the plaque's fibrous cap | The only drug class that treats the disease process itself; in secondary prevention the target is set low, and it is not optional |
| Beta blocker | Slows the heart and lowers its workload | Relieves angina and, after a heart attack, protects the healing muscle |
| ACE inhibitor / ARB | Lowers blood pressure and reduces the remodelling that follows injury | Protects the heart muscle and the kidneys — particularly important in diabetes |
| Nitrates | Widen the arteries briefly — under the tongue for an attack, longer-acting forms for prevention | Symptom control; they treat the complaint but not the disease |
One paragraph of honesty belongs here, because patients ask: medicine alone is a complete treatment for many patients with stable disease, and trials have shown that in stable, well-selected patients a strategy of good medicine without a stent serves as well as a stent plus medicine. That finding is not an argument against stents — it is the reason stents are spent where they earn their place, which is the subject of the rest of this page.
Angioplasty and stents: what the procedure is, and when it is the answer
Percutaneous coronary intervention (PCI) — angioplasty with a stent — treats a narrowing from inside the artery. Under local anaesthetic, through the wrist artery in most cases (patients sit up and walk the same day), a catheter carries a balloon to the narrowing; the balloon opens it, and a stent — a small metal scaffold — is expanded to hold the artery open. The modern stent is a drug-eluting stent, coated with a medicine that slows the scarring reaction which once re-narrowed treated arteries; bioresorbable scaffolds, which dissolve over years, are also part of our practice.
PCI is the clear answer in three situations: when a narrowing that the pressure wire shows is starving the muscle and medicine has not controlled the symptoms; when an acute coronary syndrome is in progress and the blocked artery must be opened — the clock treatment; and for the complex anatomy our teams are set up for and other centres refer on:
- Left main stenting — the artery supplying most of the heart, where technique and case selection decide the outcome.
- Chronic total occlusion (CTO) — arteries blocked for months or years, reopening of which is a procedural subspecialty with dedicated wires, strategies and experience.
- Multivessel PCI — staged or single-sitting treatment of several arteries, planned around the pressure-wire results rather than the film appearance.
A stent is not a cure — it holds one segment of one artery open, and the disease process is still managed by the medicines above. What it buys is a specific, measured thing: flow restored to muscle that was being starved, and the emergency reopened.
Bypass surgery: rebuilding the supply
Coronary artery bypass grafting (CABG) takes healthy vessels from elsewhere — usually an artery from inside the chest (the internal mammary artery, which has the best long-term durability) and a vein or artery from the leg or arm — and grafts them from the aorta to the coronary artery beyond the blockages. It rebuilds the supply rather than repairing the pipe, which is why its results hold for decades and why complex anatomy is its natural territory.
Our surgical practice is supported inside the same hospital: coronary surgery with on-site backup, and intra-aortic balloon pump (IABP) support for patients whose hearts need mechanical assistance around the operation. The recovery is longer than angioplasty's — the sternum needs weeks to knit, and driving, lifting and returning to work follow that clock — and that difference is a legitimate part of the comparison, not a detail.
Stent or bypass: how the choice is actually made
This is the question patients carry into the clinic, and the honest answer is that it is decided by a small number of anatomy-and-patient factors rather than by preference or by which specialist the patient saw first:
| Factor | Favours a stent | Favours bypass |
|---|---|---|
| Number of arteries | A single vessel, or one significant narrowing | Two or three vessels, especially when several territories are at risk |
| Left main artery | Selected left main disease, in experienced teams, with lower complexity | Left main combined with multivessel disease — the classic surgical territory |
| Diabetes | Single-vessel or limited disease | Multivessel disease — surgery has shown better long-term outcomes in this group |
| Artery suitability | Vessels the wire can reach; no chronic total occlusion, or a CTO with favourable anatomy | Diffuse disease, heavy calcification, or blockages unsuitable for a wire |
| Muscle state | Good pumping function | Weakened muscle, where complete revascularisation matters more |
| Patient factors | Need for a fast recovery; higher surgical risk from age or other illness | Fit for surgery; values long-term durability over recovery time |
In the middle ground — the patients these columns do not cleanly separate — the decision is made by a heart team: the interventional cardiologist and the surgeon reviewing the same images together, which is why the anatomy is scored and discussed rather than decided in a single clinic. A patient being offered a major procedure without that comparison having been visible deserves to ask for it.
Cardiac rehabilitation: the part that decides whether it holds
Revascularisation fixes the anatomy; rehabilitation rebuilds the patient's capacity and the habits that keep the arteries stable. A structured programme combines graded exercise training, risk-factor education — lipids, blood pressure, diabetes, smoking — psychological support and a return-to-activity plan, run by a team rather than handed over as a leaflet. Our Foshan hospital holds a national cardiac rehabilitation certification, and the programme is available to international patients with coordination before and after the flight home
The emergency pathway: a heart attack on arrival
For the acute syndromes the plan collapses to one line: open the artery. Emergency cardiac intervention runs around the clock at both flagship hospitals — the on-call catheterisation team, the chest-pain pathway (a nationally certified centre at Foshan), and the coronary care unit behind it. For the international patient already under our care, the practical meaning is this: the emergency pathway does not begin with translation or administration — the angiogram films reviewed before travel, the plan agreed in advance, and the 24/7 service are the same service a local patient would meet.
After the procedure: recovery, follow-up and going home
- After angioplasty: most patients walk the same day and fly home within days; the wrist artery needs days of care, the dual antiplatelet therapy usually continues for a defined period set by the stent and the event — commonly in the range of six to twelve months, individualised — and then usually steps down to a single agent.
- After bypass: the sternum dictates the calendar — weeks for the bone to knit before driving or lifting, with return to desk work and to heavier activity staged accordingly; the grafts, once proven, hold for years.
- The medical foundation never stops: the statin, the blood-pressure control and the antiplatelet therapy are the treatment that keeps the result — stopping them because the chest no longer hurts is the most consequential error of the years after any procedure.
- Follow-up from home: symptom review, medication adjustment and the risk-factor numbers continue remotely; imaging or testing is repeated when the symptoms, not the calendar, ask for it.